Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine

John S. Lambert, D. Heather Watts, Lynne Mofenson, E. Richard Stiehm, D. Robert Harris, James Bethel, Jean Whitehouse, Eleanor Jimenez, Jorge Gandia, Gwendolyn B Scott, Mary Jo O'Sullivan, Andrea Kovacs, Alice Stek, William T. Shearer, Hunter Hammill, Russell Van Dyke, Robert Maupin, Maggie Silio, Mary Glenn Fowler

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: To evaluate independent contributions of maternal factors to adverse pregnancy outcomes (APO) in HIV-infected women receiving antiretroviral therapy (ART). Design: Risk factors for preterm birth (< 37 weeks gestation), low birth weight (LBW) (< 2500 g), and intrauterine growth retardation (IUGR) (birth weight < 10(th) percentile for gestational age) examined in 497 HIV-infected pregnant women enrolled in PACTG 185, a perinatal clinical trial. Methods: HIV RNA copy number, culture titer, and CD4 lymphocyte counts were measured during pregnancy. Information collected included antenatal use of cigarettes, alcohol, illicit drugs; ART; obstetric history and complications. Results: Eighty-six percent were minority race/ethnicity; 86% received antenatal monotherapy, predominantly zidovudine (ZDV), and 14% received combination antiretrovirals. Preterm birth occurred in 17%, LBW in 13%, IUGR in 6%. Risk of preterm birth was independently associated with prior preterm birth [odds ratio (OR) 3.34; P < 0.001], multiple gestation (OR, 6.02; P = 0.011), antenatal alcohol use (OR, 1.91; P = 0.038), and antenatal diagnosis of genital herpes (OR, 0.24; P = 0.022) or pre-eclampsia (OR, 6.36; P = 0.025). LBW was associated with antenatal diagnosis of genital herpes (OR, 0.08; P = 0.014) and pre-eclampsia (OR, 5.25; P = 0.049), and baseline HIV culture titer (OR, 1.41; P = 0.037). IUGR was associated with multiple gestation (OR, 8.20; P = 0.010), antenatal cigarette use (OR, 3.60; P = 0.008), and pre-eclampsia (OR, 12.90; P = 0.007). Maternal immune status and HIV RNA copy number were not associated with APO. Conclusions: Risk factors for APO in antiretroviral treated HIV-infected women are similar to those reported for uninfected women. These data suggest that provision of prenatal care and ART may reduce APO. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish
Pages (from-to)1389-1399
Number of pages11
JournalAIDS
Volume14
Issue number10
DOIs
StatePublished - Jul 28 2000
Externally publishedYes

Fingerprint

Fetal Growth Retardation
Zidovudine
Premature Birth
Low Birth Weight Infant
Pregnant Women
Odds Ratio
HIV
Pregnancy Outcome
Pre-Eclampsia
Herpes Genitalis
Pregnancy
Prenatal Diagnosis
Tobacco Products
Alcohols
Mothers
RNA
Prenatal Care
Street Drugs
CD4 Lymphocyte Count
Birth Weight

Keywords

  • Antiretroviral therapy
  • HIV
  • Intrauterine growth retardation
  • Low birth weight
  • Pregnancy
  • Preterm birth
  • Vertical infection
  • Zidovudine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. / Lambert, John S.; Watts, D. Heather; Mofenson, Lynne; Stiehm, E. Richard; Harris, D. Robert; Bethel, James; Whitehouse, Jean; Jimenez, Eleanor; Gandia, Jorge; Scott, Gwendolyn B; O'Sullivan, Mary Jo; Kovacs, Andrea; Stek, Alice; Shearer, William T.; Hammill, Hunter; Van Dyke, Russell; Maupin, Robert; Silio, Maggie; Fowler, Mary Glenn.

In: AIDS, Vol. 14, No. 10, 28.07.2000, p. 1389-1399.

Research output: Contribution to journalArticle

Lambert, JS, Watts, DH, Mofenson, L, Stiehm, ER, Harris, DR, Bethel, J, Whitehouse, J, Jimenez, E, Gandia, J, Scott, GB, O'Sullivan, MJ, Kovacs, A, Stek, A, Shearer, WT, Hammill, H, Van Dyke, R, Maupin, R, Silio, M & Fowler, MG 2000, 'Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine', AIDS, vol. 14, no. 10, pp. 1389-1399. https://doi.org/10.1097/00002030-200007070-00012
Lambert, John S. ; Watts, D. Heather ; Mofenson, Lynne ; Stiehm, E. Richard ; Harris, D. Robert ; Bethel, James ; Whitehouse, Jean ; Jimenez, Eleanor ; Gandia, Jorge ; Scott, Gwendolyn B ; O'Sullivan, Mary Jo ; Kovacs, Andrea ; Stek, Alice ; Shearer, William T. ; Hammill, Hunter ; Van Dyke, Russell ; Maupin, Robert ; Silio, Maggie ; Fowler, Mary Glenn. / Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. In: AIDS. 2000 ; Vol. 14, No. 10. pp. 1389-1399.
@article{2fe291d773f545b5918b7ba0c6fa5092,
title = "Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine",
abstract = "Objective: To evaluate independent contributions of maternal factors to adverse pregnancy outcomes (APO) in HIV-infected women receiving antiretroviral therapy (ART). Design: Risk factors for preterm birth (< 37 weeks gestation), low birth weight (LBW) (< 2500 g), and intrauterine growth retardation (IUGR) (birth weight < 10(th) percentile for gestational age) examined in 497 HIV-infected pregnant women enrolled in PACTG 185, a perinatal clinical trial. Methods: HIV RNA copy number, culture titer, and CD4 lymphocyte counts were measured during pregnancy. Information collected included antenatal use of cigarettes, alcohol, illicit drugs; ART; obstetric history and complications. Results: Eighty-six percent were minority race/ethnicity; 86{\%} received antenatal monotherapy, predominantly zidovudine (ZDV), and 14{\%} received combination antiretrovirals. Preterm birth occurred in 17{\%}, LBW in 13{\%}, IUGR in 6{\%}. Risk of preterm birth was independently associated with prior preterm birth [odds ratio (OR) 3.34; P < 0.001], multiple gestation (OR, 6.02; P = 0.011), antenatal alcohol use (OR, 1.91; P = 0.038), and antenatal diagnosis of genital herpes (OR, 0.24; P = 0.022) or pre-eclampsia (OR, 6.36; P = 0.025). LBW was associated with antenatal diagnosis of genital herpes (OR, 0.08; P = 0.014) and pre-eclampsia (OR, 5.25; P = 0.049), and baseline HIV culture titer (OR, 1.41; P = 0.037). IUGR was associated with multiple gestation (OR, 8.20; P = 0.010), antenatal cigarette use (OR, 3.60; P = 0.008), and pre-eclampsia (OR, 12.90; P = 0.007). Maternal immune status and HIV RNA copy number were not associated with APO. Conclusions: Risk factors for APO in antiretroviral treated HIV-infected women are similar to those reported for uninfected women. These data suggest that provision of prenatal care and ART may reduce APO. (C) 2000 Lippincott Williams and Wilkins.",
keywords = "Antiretroviral therapy, HIV, Intrauterine growth retardation, Low birth weight, Pregnancy, Preterm birth, Vertical infection, Zidovudine",
author = "Lambert, {John S.} and Watts, {D. Heather} and Lynne Mofenson and Stiehm, {E. Richard} and Harris, {D. Robert} and James Bethel and Jean Whitehouse and Eleanor Jimenez and Jorge Gandia and Scott, {Gwendolyn B} and O'Sullivan, {Mary Jo} and Andrea Kovacs and Alice Stek and Shearer, {William T.} and Hunter Hammill and {Van Dyke}, Russell and Robert Maupin and Maggie Silio and Fowler, {Mary Glenn}",
year = "2000",
month = "7",
day = "28",
doi = "10.1097/00002030-200007070-00012",
language = "English",
volume = "14",
pages = "1389--1399",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine

AU - Lambert, John S.

AU - Watts, D. Heather

AU - Mofenson, Lynne

AU - Stiehm, E. Richard

AU - Harris, D. Robert

AU - Bethel, James

AU - Whitehouse, Jean

AU - Jimenez, Eleanor

AU - Gandia, Jorge

AU - Scott, Gwendolyn B

AU - O'Sullivan, Mary Jo

AU - Kovacs, Andrea

AU - Stek, Alice

AU - Shearer, William T.

AU - Hammill, Hunter

AU - Van Dyke, Russell

AU - Maupin, Robert

AU - Silio, Maggie

AU - Fowler, Mary Glenn

PY - 2000/7/28

Y1 - 2000/7/28

N2 - Objective: To evaluate independent contributions of maternal factors to adverse pregnancy outcomes (APO) in HIV-infected women receiving antiretroviral therapy (ART). Design: Risk factors for preterm birth (< 37 weeks gestation), low birth weight (LBW) (< 2500 g), and intrauterine growth retardation (IUGR) (birth weight < 10(th) percentile for gestational age) examined in 497 HIV-infected pregnant women enrolled in PACTG 185, a perinatal clinical trial. Methods: HIV RNA copy number, culture titer, and CD4 lymphocyte counts were measured during pregnancy. Information collected included antenatal use of cigarettes, alcohol, illicit drugs; ART; obstetric history and complications. Results: Eighty-six percent were minority race/ethnicity; 86% received antenatal monotherapy, predominantly zidovudine (ZDV), and 14% received combination antiretrovirals. Preterm birth occurred in 17%, LBW in 13%, IUGR in 6%. Risk of preterm birth was independently associated with prior preterm birth [odds ratio (OR) 3.34; P < 0.001], multiple gestation (OR, 6.02; P = 0.011), antenatal alcohol use (OR, 1.91; P = 0.038), and antenatal diagnosis of genital herpes (OR, 0.24; P = 0.022) or pre-eclampsia (OR, 6.36; P = 0.025). LBW was associated with antenatal diagnosis of genital herpes (OR, 0.08; P = 0.014) and pre-eclampsia (OR, 5.25; P = 0.049), and baseline HIV culture titer (OR, 1.41; P = 0.037). IUGR was associated with multiple gestation (OR, 8.20; P = 0.010), antenatal cigarette use (OR, 3.60; P = 0.008), and pre-eclampsia (OR, 12.90; P = 0.007). Maternal immune status and HIV RNA copy number were not associated with APO. Conclusions: Risk factors for APO in antiretroviral treated HIV-infected women are similar to those reported for uninfected women. These data suggest that provision of prenatal care and ART may reduce APO. (C) 2000 Lippincott Williams and Wilkins.

AB - Objective: To evaluate independent contributions of maternal factors to adverse pregnancy outcomes (APO) in HIV-infected women receiving antiretroviral therapy (ART). Design: Risk factors for preterm birth (< 37 weeks gestation), low birth weight (LBW) (< 2500 g), and intrauterine growth retardation (IUGR) (birth weight < 10(th) percentile for gestational age) examined in 497 HIV-infected pregnant women enrolled in PACTG 185, a perinatal clinical trial. Methods: HIV RNA copy number, culture titer, and CD4 lymphocyte counts were measured during pregnancy. Information collected included antenatal use of cigarettes, alcohol, illicit drugs; ART; obstetric history and complications. Results: Eighty-six percent were minority race/ethnicity; 86% received antenatal monotherapy, predominantly zidovudine (ZDV), and 14% received combination antiretrovirals. Preterm birth occurred in 17%, LBW in 13%, IUGR in 6%. Risk of preterm birth was independently associated with prior preterm birth [odds ratio (OR) 3.34; P < 0.001], multiple gestation (OR, 6.02; P = 0.011), antenatal alcohol use (OR, 1.91; P = 0.038), and antenatal diagnosis of genital herpes (OR, 0.24; P = 0.022) or pre-eclampsia (OR, 6.36; P = 0.025). LBW was associated with antenatal diagnosis of genital herpes (OR, 0.08; P = 0.014) and pre-eclampsia (OR, 5.25; P = 0.049), and baseline HIV culture titer (OR, 1.41; P = 0.037). IUGR was associated with multiple gestation (OR, 8.20; P = 0.010), antenatal cigarette use (OR, 3.60; P = 0.008), and pre-eclampsia (OR, 12.90; P = 0.007). Maternal immune status and HIV RNA copy number were not associated with APO. Conclusions: Risk factors for APO in antiretroviral treated HIV-infected women are similar to those reported for uninfected women. These data suggest that provision of prenatal care and ART may reduce APO. (C) 2000 Lippincott Williams and Wilkins.

KW - Antiretroviral therapy

KW - HIV

KW - Intrauterine growth retardation

KW - Low birth weight

KW - Pregnancy

KW - Preterm birth

KW - Vertical infection

KW - Zidovudine

UR - http://www.scopus.com/inward/record.url?scp=0033941736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033941736&partnerID=8YFLogxK

U2 - 10.1097/00002030-200007070-00012

DO - 10.1097/00002030-200007070-00012

M3 - Article

VL - 14

SP - 1389

EP - 1399

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 10

ER -